In ModernaTx, Inc. v. Arbutus Biopharma Corp., the Federal Circuit agreed with Arbutus that Moderna lacked standing at the time it filed its appeal, and determined that Moderna failed to demonstrate that it had standing throughout the pendency of the appeal.